Seock Ah Im

1.1k total citations
23 papers, 806 citations indexed

About

Seock Ah Im is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Seock Ah Im has authored 23 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Seock Ah Im's work include Cancer Treatment and Pharmacology (4 papers), HER2/EGFR in Cancer Research (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Seock Ah Im is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), HER2/EGFR in Cancer Research (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Seock Ah Im collaborates with scholars based in South Korea, United States and France. Seock Ah Im's co-authors include Ahrum Min, Keun Seok Lee, Min Young Lee, Jungsil Ro, Chul Soo Kim, Winnie Yeo, Hyun Cheol Chung, Sung‐Bae Kim, Sun Young Rha and Ke Li and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Bone and Mineral Research.

In The Last Decade

Seock Ah Im

21 papers receiving 786 citations

Peers

Seock Ah Im

BIOMA

ONCOL

L. Tiffany Lyle United States

Jiabei He China

Masako Oka Japan

Feifei Yang China

Vessela Vassileva United Kingdom

Caterina Fotia Italy

Henrike Caysa Germany

Isaac M. Adjei United States

Richard H. Lark United States

Ela Markovsky Israel

L. Tiffany Lyle United States

Seock Ah Im

187 ×0.6

BIOMA

382 ×1.2

178 ×0.6

ONCOL

203 ×0.9

114 ×1.0

Citations per year, relative to Seock Ah Im Seock Ah Im (= 1×) peers L. Tiffany Lyle

Countries citing papers authored by Seock Ah Im

Since Specialization

Citations

This map shows the geographic impact of Seock Ah Im's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seock Ah Im with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seock Ah Im more than expected).

Fields of papers citing papers by Seock Ah Im

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seock Ah Im. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seock Ah Im. The network helps show where Seock Ah Im may publish in the future.

Co-authorship network of co-authors of Seock Ah Im

This figure shows the co-authorship network connecting the top 25 collaborators of Seock Ah Im. A scholar is included among the top collaborators of Seock Ah Im based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seock Ah Im. Seock Ah Im is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, So Hyeon, Young Joo Park, Ahrum Min, et al.. (2025). DNA damage and Nuclear Anaplasia Induced by Trastuzumab Deruxtecan in Cancer Cells with Variable HER2 Expression and Homologous Recombination Deficiency Status. Cancer Research and Treatment. 1 indexed citations

Lee, Kyung-Hun, Kyoung Jin Lee, Tae‐Yong Kim, et al.. (2020). Circulating Osteocalcin-Positive Cells as a Novel Diagnostic Biomarker for Bone Metastasis in Breast Cancer Patients. Journal of Bone and Mineral Research. 35(10). 1838–1849. 17 indexed citations

Min, Ahrum & Seock Ah Im. (2020). PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation. Cancers. 12(2). 394–394. 101 indexed citations

Pivot, Xavier, Seock Ah Im, Matthew Guo, & Frederik Marmé. (2018). Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine. Breast Cancer. 25(3). 370–374. 21 indexed citations

Kim, Hee Jeong, Moo Hyun Lee, Joon Jeong, et al.. (2018). Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy. Clinical Breast Cancer. 18(5). e1165–e1172. 4 indexed citations

Kim, Kyubo, Eui Kyu Chie, Wonshik Han, et al.. (2011). Concurrent versus sequential administration of CMF chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer.. PubMed. 97(3). 280–5. 5 indexed citations

Kim, Ji Won, Ji Hyun Kwon, Do Youn Oh, et al.. (2010). A case of primary breast synovial sarcoma diagnosed in a young female patient. The Korean Journal of Internal Medicine. 78(5). 640–644. 2 indexed citations

Lee, Kyung Hee, Min Kyoung Kim, Yeul Hong Kim, et al.. (2008). Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study. Cancer Chemotherapy and Pharmacology. 64(2). 317–325. 17 indexed citations

Lee, Keun Seok, Hyun Cheol Chung, Seock Ah Im, et al.. (2007). Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer. Breast Cancer Research and Treatment. 108(2). 241–250. 402 indexed citations

10.

Oh, Do Youn, Jee Hyun Kim, Se‐Hoon Lee, et al.. (2006). Artificial nutrition and hydration in terminal cancer patients: the real and the ideal. Supportive Care in Cancer. 15(6). 631–636. 18 indexed citations

11.

Jung, Sung-Ae, Suk Kyun Yang, Ki‐Nam Shim, et al.. (2005). [The expression of matrix metalloproteinases (MMPs), tissue inhibitor of metalloproteinases (TIMPs) and angiogenesis in relation to the depth of tumor invasion and lymph node metastasis in submucosally invasive colorectal carcinoma].. PubMed. 45(6). 401–8. 6 indexed citations

12.

Park, Se Hoon, Soo‐Mee Bang, Eun Kyung Cho, et al.. (2004). First-Line Chemotherapy with Irinotecan plus Capecitabine for Advanced Colorectal Cancer. Oncology. 66(5). 353–357. 28 indexed citations

13.

Bang, Soo‐Mee, Jae Hoon Lee, Sung‐Soo Yoon, et al.. (2004). Preliminary Report of Risk-Based Approach in Korean Patients with Newly Diagnosed Multiple Myeloma.. Blood. 104(11). 4911–4911. 3 indexed citations

14.

Kim, Yun Hee, et al.. (2003). 적혈구, 혈소판 및 신선동결혈장 수혈의 적정성 평가. The Korean Journal of Laboratory Medicine. 23(6). 448–454. 3 indexed citations

15.

Kim, Jeong Soo, et al.. (2003). A Clinical Analysis of PTEN Expressions in Breast Cancers. Cancer Research and Treatment. 35(2). 102–108. 1 indexed citations

16.

Im, Seock Ah, Jung Mi Kwon, Kyung Eun Lee, et al.. (2002). A Case of Primary Gastric Choriocarcinoma Presenting with Amenorrhea. Cancer Research and Treatment. 34(6). 457–460. 2 indexed citations

17.

Kim, Jeong Soo, et al.. (2001). Apoptosis Related Protein Expressions in Immunohistochemical Staining Using Tissue Microarrays of Breast Cancer. 4(2). 179–179. 1 indexed citations

18.

Lee, Kyung Eun, et al.. (2001). Clinical Features and Prognosis of Lung Cancer with Brain Metastasis. Cancer Research and Treatment. 33(3). 250–255. 1 indexed citations

19.

Li, Ke, et al.. (2000). The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines.. PubMed. 6(6). 2562–72. 63 indexed citations

20.

Im, Seock Ah, Candelaria Gomez‐Manzano, Juàn Fueyo, et al.. (1999). Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo.. PubMed. 59(4). 895–900. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact